Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80


The CNS in inbred transgenic models of 4-repeat Tauopathy develops consistent tau seeding capacity yet focal and diverse patterns of protein deposition.

Eskandari-Sedighi G, Daude N, Gapeshina H, Sanders DW, Kamali-Jamil R, Yang J, Shi B, Wille H, Ghetti B, Diamond MI, Janus C, Westaway D.

Mol Neurodegener. 2017 Oct 4;12(1):72. doi: 10.1186/s13024-017-0215-7.


Protein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Continuum.

Shahheydari H, Ragagnin A, Walker AK, Toth RP, Vidal M, Jagaraj CJ, Perri ER, Konopka A, Sultana JM, Atkin JD.

Front Mol Neurosci. 2017 May 10;10:119. doi: 10.3389/fnmol.2017.00119. eCollection 2017.


Prion-like Spreading in Tauopathies.

Ayers JI, Giasson BI, Borchelt DR.

Biol Psychiatry. 2018 Feb 15;83(4):337-346. doi: 10.1016/j.biopsych.2017.04.003. Epub 2017 Apr 13. Review.


Frontotemporal Dementia.

Olney NT, Spina S, Miller BL.

Neurol Clin. 2017 May;35(2):339-374. doi: 10.1016/j.ncl.2017.01.008. Review.


Frontotemporal dementia with the V337M MAPT mutation: Tau-PET and pathology correlations.

Spina S, Schonhaut DR, Boeve BF, Seeley WW, Ossenkoppele R, O'Neil JP, Lazaris A, Rosen HJ, Boxer AL, Perry DC, Miller BL, Dickson DW, Parisi JE, Jagust WJ, Murray ME, Rabinovici GD.

Neurology. 2017 Feb 21;88(8):758-766. doi: 10.1212/WNL.0000000000003636. Epub 2017 Jan 27.


Assessment of Olfactory Function in MAPT-Associated Neurodegenerative Disease Reveals Odor-Identification Irreproducibility as a Non-Disease-Specific, General Characteristic of Olfactory Dysfunction.

Markopoulou K, Chase BA, Robowski P, Strongosky A, Narożańska E, Sitek EJ, Berdynski M, Barcikowska M, Baker MC, Rademakers R, Sławek J, Klein C, Hückelheim K, Kasten M, Wszolek ZK.

PLoS One. 2016 Nov 17;11(11):e0165112. doi: 10.1371/journal.pone.0165112. eCollection 2016.


Reduction of Nuak1 Decreases Tau and Reverses Phenotypes in a Tauopathy Mouse Model.

Lasagna-Reeves CA, de Haro M, Hao S, Park J, Rousseaux MW, Al-Ramahi I, Jafar-Nejad P, Vilanova-Velez L, See L, De Maio A, Nitschke L, Wu Z, Troncoso JC, Westbrook TF, Tang J, Botas J, Zoghbi HY.

Neuron. 2016 Oct 19;92(2):407-418. doi: 10.1016/j.neuron.2016.09.022. Epub 2016 Oct 6.


NMR Meets Tau: Insights into Its Function and Pathology.

Lippens G, Landrieu I, Smet C, Huvent I, Gandhi NS, Gigant B, Despres C, Qi H, Lopez J.

Biomolecules. 2016 Jun 7;6(2). pii: E28. doi: 10.3390/biom6020028. Review.


Mouse Genetic Models of Human Brain Disorders.

Leung C, Jia Z.

Front Genet. 2016 Mar 23;7:40. doi: 10.3389/fgene.2016.00040. eCollection 2016. Review.


Oligomerization of the microtubule-associated protein tau is mediated by its N-terminal sequences: implications for normal and pathological tau action.

Feinstein HE, Benbow SJ, LaPointe NE, Patel N, Ramachandran S, Do TD, Gaylord MR, Huskey NE, Dressler N, Korff M, Quon B, Cantrell KL, Bowers MT, Lal R, Feinstein SC.

J Neurochem. 2016 Jun;137(6):939-54. doi: 10.1111/jnc.13604. Epub 2016 Apr 20.


Pathological Tau Promotes Neuronal Damage by Impairing Ribosomal Function and Decreasing Protein Synthesis.

Meier S, Bell M, Lyons DN, Rodriguez-Rivera J, Ingram A, Fontaine SN, Mechas E, Chen J, Wolozin B, LeVine H 3rd, Zhu H, Abisambra JF.

J Neurosci. 2016 Jan 20;36(3):1001-7. doi: 10.1523/JNEUROSCI.3029-15.2016.


The effect of multivalent cations and Tau on paclitaxel-stabilized microtubule assembly, disassembly, and structure.

Safinya CR, Chung PJ, Song C, Li Y, Ewert KK, Choi MC.

Adv Colloid Interface Sci. 2016 Jun;232:9-16. doi: 10.1016/j.cis.2015.11.002. Epub 2015 Nov 11. Review.


Direct force measurements reveal that protein Tau confers short-range attractions and isoform-dependent steric stabilization to microtubules.

Chung PJ, Choi MC, Miller HP, Feinstein HE, Raviv U, Li Y, Wilson L, Feinstein SC, Safinya CR.

Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):E6416-25. doi: 10.1073/pnas.1513172112. Epub 2015 Nov 5.


Genetic Identification Is Critical for the Diagnosis of Parkinsonism: A Chinese Pedigree with Early Onset of Parkinsonism.

Yang Y, Tang BS, Weng L, Li N, Shen L, Wang J, Zuo CT, Yan XX, Xia K, Guo JF.

PLoS One. 2015 Aug 21;10(8):e0136245. doi: 10.1371/journal.pone.0136245. eCollection 2015.


Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations.

Iovino M, Agathou S, González-Rueda A, Del Castillo Velasco-Herrera M, Borroni B, Alberici A, Lynch T, O'Dowd S, Geti I, Gaffney D, Vallier L, Paulsen O, Káradóttir RT, Spillantini MG.

Brain. 2015 Nov;138(Pt 11):3345-59. doi: 10.1093/brain/awv222. Epub 2015 Jul 27.


RNA Structures as Mediators of Neurological Diseases and as Drug Targets.

Bernat V, Disney MD.

Neuron. 2015 Jul 1;87(1):28-46. doi: 10.1016/j.neuron.2015.06.012. Review.


Frontotemporal dementia parkinsonism: Clinical findings in a large Iranian family.

Basiri K, Ansari B, Meamar R.

Adv Biomed Res. 2015 Feb 11;4:37. doi: 10.4103/2277-9175.151242. eCollection 2015.


Cellular factors modulating the mechanism of tau protein aggregation.

Fontaine SN, Sabbagh JJ, Baker J, Martinez-Licha CR, Darling A, Dickey CA.

Cell Mol Life Sci. 2015 May;72(10):1863-79. doi: 10.1007/s00018-015-1839-9. Epub 2015 Feb 11. Review.


Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging.

Ghetti B, Oblak AL, Boeve BF, Johnson KA, Dickerson BC, Goedert M.

Neuropathol Appl Neurobiol. 2015 Feb;41(1):24-46. doi: 10.1111/nan.12213. Review. Erratum in: Neuropathol Appl Neurobiol. 2015 Jun;41(4):571. Neuropathol Appl Neurobiol. 2015 Jun;41(4):571.


Alpha-synuclein and tau: teammates in neurodegeneration?

Moussaud S, Jones DR, Moussaud-Lamodière EL, Delenclos M, Ross OA, McLean PJ.

Mol Neurodegener. 2014 Oct 29;9:43. doi: 10.1186/1750-1326-9-43. Review.

Supplemental Content

Support Center